‘Harbaugh Bowl,’ Subway, Verizon: Intellectual Property

Jan. 28 (Bloomberg) -- AbbVie Inc., the drug unit that split from parent Abbott Laboratories on Jan. 1, sued Indian generic drug maker Sun Pharmaceutical Industries Ltd. for infringing a U.S. patent for Zemplar, used to treat kidney patients.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.